NetScientific Release: Notice of Results
London, UK – 24 March 2016 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic biomedical and healthcare technology group, announces that it will report its final results for the 12 months ended 31 December 2015 on 07 April 2016.
An analyst presentation will be held at the offices of Consilium Strategic Communications at 41, Lothbury, EC2R 7HG at 12.00 on 07 April 2016.
- Ends –
For more information, please contact:
NetScientific François R. Martelet, M.D., CEO Mark Nanovich, Interim CFO
Tel: +44 (0)20 3514 1800
Investec (NOMAD and broker) Gary Clarence / Daniel Adams
Tel: +44 (0)20 7597 4000
Consilium Strategic Communications
Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton Tel: +44 (0)20 3709 5700
netscientific@consilium-comms.com
About NetScientific Plc
NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net.
An analyst presentation will be held at the offices of Consilium Strategic Communications at 41, Lothbury, EC2R 7HG at 12.00 on 07 April 2016.
- Ends –
For more information, please contact:
NetScientific François R. Martelet, M.D., CEO Mark Nanovich, Interim CFO
Tel: +44 (0)20 3514 1800
Investec (NOMAD and broker) Gary Clarence / Daniel Adams
Tel: +44 (0)20 7597 4000
Consilium Strategic Communications
Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton Tel: +44 (0)20 3709 5700
netscientific@consilium-comms.com
About NetScientific Plc
NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net.